RHJA
KRMD icon

Rice Hall James & Associates’s KORU Medical Systems KRMD Stock Holding History

Rice Hall James & Associates’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-441,459
Closed -$2.04M – 317
2021
Q2 		$2.04M Buy
+441,459
New +$1.73M 0.07% 210

Other funds holding KRMD

HCM
Horton Capital Management Philadelphia, Pennsylvania $44.9M AUM 24.87% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rice Hall James & Associates's KRMD Position: Q3 2021 in Review

Rice Hall James & Associates sold out of KORU Medical Systems (KRMD) in Q3 2021, closing a stake of 441,459 shares — an estimated $2.04M sold.

Rice Hall James & Associates first reported a position in KRMD in Q2 2021 and held it in 1 quarter. The position peaked at $2.04M in Q2 2021. 50 funds tracked by Wall St. Rank hold KRMD as of Q3 2021.

  • Rice Hall James & Associates reported no remaining KORU Medical Systems position as of Q3 2021 after selling out during the quarter.
  • Rice Hall James & Associates sold 441,459 KORU Medical Systems shares in Q3 2021, an estimated $2.04M.
  • Rice Hall James & Associates first reported a position in KORU Medical Systems in Q2 2021 and held it in 1 quarter.
  • Rice Hall James & Associates's KORU Medical Systems position peaked at $2.04M in Q2 2021.
  • 50 funds tracked by Wall St. Rank held KORU Medical Systems as of Q3 2021.

Based on Rice Hall James & Associates's 13F filing for Q3 2021, filed 9 Nov 2021.